Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
1.
An. bras. dermatol ; 90(6): 862-867, Nov.-Dec. 2015. graf
Article in English | LILACS | ID: lil-769527

ABSTRACT

Abstract: It is known that inflammatory and immune responses protect us from the invasion of micro-organisms and eliminate "wastes" from the injured sites, but they may also be responsible for significant tissue damage. Adenosine, as a purine nucleoside, which is produced in inflamed or injured sites, fulfills its role in limiting tissue damage. Although, it may have a pleiotropic effect, which signals it with a proinflammatory state in certain situations, it can be considered a potent anti-inflammatory mediator. The effects of adenosine, which acts through its receptors on T cell, on mast cell and macrophages, on endothelial cells, on neutrophils and dendritic cells, as they indicate TNF-alpha and cytokines, show that this mediator has a central role in the pathogenesis of psoriasis. The way it acts in psoriasis will be reviewed in this study.


Subject(s)
Humans , Adenosine/metabolism , Psoriasis/etiology , Psoriasis/metabolism , Adenosine Deaminase/metabolism , Cytokines/metabolism , Immunosuppressive Agents/metabolism , Inflammation Mediators/metabolism , Methotrexate/metabolism
2.
Rev. bras. reumatol ; 55(6): 485-492, nov.-dez. 2015. tab
Article in English | LILACS | ID: lil-770017

ABSTRACT

Resumo Introdução: Relata-se que o polimorfismo do gene timidilato sintase (TS) e a homocisteína têm relação com o metabolismo do metotrexato (MTX), com achados conflitantes. O objetivo deste estudo foi determinar os níveis de homocisteína e a frequência de polimorfismos de repetição tripla (TS3R) e dupla (TS2R) do gene TS em um grupo de pacientes turcos com AR e avaliar sua associação com a toxicidade ao MTX e a atividade da doença. Métodos: Foram incluídos no estudo 64 pacientes com AR e 31 indivíduos no grupo controle, com média de 48,7 ± 12,5 e 46,2 ± 13,4 anos. Foram obtidas as características demográficas e foi registrado o número de pacientes que relataram efeitos adversos ao MTX no grupo AR. Foram analisados os níveis de homocisteína e os polimorfismos TS2R/TS3R. Foi determinada a distribuição de genótipos de acordo com a toxicidade ao MTX e a atividade da doença. Resultados: Os dados demográficos foram semelhantes entre os pacientes e controles. Todos faziam suplementação de ácido fólico a uma dose média de 5 mg/semana. Dos 64 pacientes, 36 apresentaram efeitos adversos ao tratamento com MTX. Encontrou-se uma frequência de polimorfismos TS2R e TS3R semelhante nos grupos AR e controle. Encontrou-se que os polimorfismos TS2R e TS3R eram semelhantes em pacientes com e sem eventos adversos relacionados com o MTX. O nível médio de homocisteína também foi similar em pacientes com e sem polimorfismo do gene TS, mas era mais elevado (12,45 μmol/L vs. 10,7 μmol/L) em pacientes com do que sem efeitos adversos relacionados com o MTX. O nível médio de homocisteína se correlacionou com o VHS no grupo AR. Conclusões: Os níveis de homocisteína podem afetar a atividade da doença e a toxicidade ao MTX, mas os polimorfismos 2 R e 3 R no gene TS não se correlacionaram com a toxicidade ao MTX em pacientes com AR que recebem suplementação de ácido fólico. São necessários mais estudos para esclarecer os polimorfismos em outras enzimas que podem ser responsáveis pela toxicidade ao MTX em pacientes com AR.


Abstract Background: The polymorphism of thymidylate synthase (TS) gene and homocysteine are reported to have a relationship to methotrexate (MTX) metabolism, with conflicting results. The aim of this study was to determine homocysteine levels and the frequency of TS gene triple repeat (TS3R) and double repeat (TS2R) polymorphisms in a group of Turkish RA patients and evaluate its association with MTX toxicity and disease activity. Methods: Sixty-four patients with RA and 31 control subjects with a mean age of 48.7 ± 12.5 and 46.2 ± 13.4 years were enrolled for the study. Demographic characteristics were obtained and a number of patients with MTX-related adverse affects were recorded in the patient group. The homocysteine levels and TS2R/TS3R polymorphisms of the TS gene were analyzed and the distribution of genotypes according to MTX toxicity and disease activity was determined. Results: The demographic properties were similar between the patient and control subjects. Folic acid supplementation with a mean dose of 5 mg folic acid/week was present in all patients. Thirty-six of the 64 patients showed adverse effects to MTX treatment. The respective frequency of TS2R and TS3R polymorphisms was found to be similar in the patient and control groups. TS2R and TS3R gene polymorphisms were found to be similar in patients with and without MTX-related adverse events. The mean homocysteine level was also similar in patients with and without TS gene polymorphism, but was found to be higher (12.45 μmol/L vs 10.7 μmol/L) in patients with MTX-related side effects than in patients without side effects. The mean level of homocysteine was correlated with levels of ESR in the patient group. Conclusions: In conclusion, homocysteine levels might affect the disease activity and toxicity of MTX but 2R and 3R polymorphisms in the TS gene were not related with MTX-related toxicity in RA patients receiving folate supplementation. Further studies are needed to illuminate the polymorphisms in other enzymes that might be responsible for the MTX toxicity in patients suffering from RA.


Subject(s)
Humans , Male , Female , Adult , Polymorphism, Genetic , Arthritis, Rheumatoid/enzymology , Arthritis, Rheumatoid/blood , Thymidylate Synthase/genetics , Methotrexate/adverse effects , Antirheumatic Agents/adverse effects , Homocysteine/blood , Arthritis, Rheumatoid/drug therapy , Vitamin B Complex/administration & dosage , Case-Control Studies , Methotrexate/metabolism , Antirheumatic Agents/metabolism , Folic Acid/administration & dosage , Middle Aged
3.
Int. j. morphol ; 24(3): 417-422, sept. 2006. ilus
Article in Spanish | LILACS | ID: lil-474606

ABSTRACT

El metotrexato es ampliamente usado en la terapia de varias enfermedades malignas. El presente trabajo fue diseñado para investigar los cambios histológicos e histoquímicos del hígado de rata albina, después de administrar dicho fármaco. Se usaron 15 ratas albinas, machos, adultas, que fueron divididas en 3 grupos: El grupo I no tuvo tratamiento correspondiendo al control. A los grupos II y III se les administró, por vía intraperitoneal, una solución salina normal y metotrexato, respectivamente, con una dosificación de 0,5 mg por Kg de peso, dos veces por semana, con una duración total de 3, 6 y 9 semanas. Las ratas fueron sacrificadas y los hígados extraídos y procesados para los estudios histológico e histoquímico. El examen de los hígados del grupo III mostró infiltración celular mononuclear y un incremento en la cantidad de fibras colágenas en la vía portal. Hubo áreas focales de necrosis de células hepáticas con distorsión de la arquitectura hepática normal. Además, hubo un gradual y progresivo decrecimiento del contenido de glicógeno en los hepatocitos. La actividad de deshidrogenasa succínica y fosfatas alcalinas también disminuyó, pero sí hubo un aumento de la actividad de las fosfatasas ácidas en las áreas degeneradas y pérdida de actividades en áreas de necrosis celular masiva. En conclusión, inyecciones repetidas de metotrexato causan daño hepático de maginitud definida. Esta hepatotoxicidad progresó a medida que las dosis se fueron acumulando. El presente estudio muestra evidencias claras de la potencia citotóxica de este medicamento.


Methotrexate (MTX) is widely used in the therapy of various types of malignancy. The present work was designed to investigate the histological and histochemical changes in the liver of albino rat following methotrexate administration. Fifteen adult male albino rats were used in the present work. They were divided into three main groups: Group I was kept without treatment and served as control. Groups II and III were given intraperitoneal injections of normal saline and MTX, respectively, at a dosage of (0.5 mg/Kg) twice weekly for total durations of 3, 6 and 9 weeks. The rats were sacrificed and the livers were excised and processed for histological and histochemical study. Examination of sections of the livers of group III showed mononuclear cell infiltration and an increase in the amount of collagen fibers in the portal tracts. There were focal areas of liver cell necrosis with distortion of the normal hepatic architecture. Moreover, there was a gradual and progressive decrease of glycogen content in the hepatocytes. Furthermore, succinic dehydrogenase and alkaline phosphatase activity were also decreased. In addition there was an increase in acid phosphatase activities in the degenerated areas and loss of activities in areas of massive cellular necrosis. It was concluded that repeated injections of MTX causes hepatic damage of a definite magnitude. This hepatotoxicity progressed with increasing cumulative doses of methotrexate. The present study provided further evidence to the cytotoxic potency of this antifolate.


Subject(s)
Animals , Male , Adult , Rats , Hepatocytes , Hepatocytes/metabolism , Methotrexate/metabolism , Methotrexate/toxicity , Liver/anatomy & histology , Liver/metabolism , Rats/anatomy & histology , Rats/metabolism
4.
Experimental & Molecular Medicine ; : 204-212, 2005.
Article in English | WPRIM | ID: wpr-201941

ABSTRACT

The organic anion transporters (OAT) have recently been identified. Although the some transport properties of OATs in the kidney have been verified, the regulatory mechanisms for OAT's functions are still not fully understood. The rat OAT1 (rOAT1) transports a number of negatively charged organic compounds between the cells and their extracellular milieu. Caveolin (Cav) also plays a role in membrane transport. Therefore, we investigated the protein-protein interactions between rOAT1 and caveolin-2. In the rat kidney, the expressions of rOAT1 mRNA and protein were observed in both the cortex and the outer medulla. With respect to Cav-2, the expressions of mRNA and protein were observed in all portions of the kidney (cortex < outer medulla = inner medulla). The results of Western blot analysis using the isolated caveolae-enriched membrane fractions or the immunoprecipitates by respective antibodies from the rat kidney showed that rOAT1 and Cav-2 co-localized in the same fractions and they formed complexes each other. These results were confirmed by performing confocal microscopy with immunocytochemistry using the primary cultured renal proximal tubular cells. When the synthesized cRNA of rOAT1 along with the antisense oligodeoxynucleotides of Xenopus Cav-2 were co-injected into Xenopus oocytes, the [14C]p-aminohippurate and [3H]methotrexate uptake was slightly, but significantly decreased. The similar results were also observed in rOAT1 over-expressed Chinese hamster ovary cells. These findings suggest that rOAT1 and caveolin-2 are co-expressed in the plasma membrane and rOAT1's function for organic compound transport is upregulated by Cav-2 in the normal physiological condition.


Subject(s)
Animals , Rats , Biological Transport, Active/physiology , CHO Cells , Caveolins/metabolism , Cell Membrane/metabolism , Cells, Cultured , Cricetinae , Immunoprecipitation , Kidney Tubules, Proximal/metabolism , Methotrexate/metabolism , Microscopy, Confocal , Oligonucleotides, Antisense/pharmacology , Oocytes/metabolism , Organic Anion Transport Protein 1/antagonists & inhibitors , RNA, Complementary/metabolism , RNA, Messenger/genetics , Xenopus laevis/metabolism , p-Aminohippuric Acid/metabolism
5.
J Biosci ; 2001 Sep; 26(3): 333-9
Article in English | IMSEAR | ID: sea-111090

ABSTRACT

CaMDR1 encodes a major facilitator superfamily (MFS) protein in Candida albicans whose expression has been linked to azole resistance and which is frequently encountered in this human pathogenic yeast. In this report we have overexpressed CaMdr1p in Sf9 insect cells and demonstrated for the first time that it can mediate methotrexate (MTX) and fluconazole (FLC) transport. MTX appeared to be a better substrate for CaMdr1p among these two tested drugs. Due to severe toxicity of these drugs to insect cells, further characterization of CaMdr1p as a drug transporter could not be done with this system. Therefore, as an alternative, CaMdr1p and Cdr1p, which is an ABC protein (ATP binding cassette) also involved in azole resistance in C. albicans, were independently expressed in a common hypersensitive host JG436 of Saccharomyces cerevisiae. This allowed a better comparison between the functionality of the two export pumps. We observed that while both FLC and MTX are effluxed by CaMdr1p, MTX appeared to be a poor substrate for Cdr1p. JG436 cells expressing Cdr1p thus conferred resistance to other antifungal drugs but remained hypersensitive to MTX. Since MTX is preferentially transported by CaMdr1p, it can be used for studying the function of this MFS protein.


Subject(s)
Antifungal Agents/metabolism , Antimetabolites, Antineoplastic/metabolism , Binding Sites , Biological Transport , Candida albicans/drug effects , Cell Line , Cloning, Molecular , Drug Resistance, Multiple, Fungal/physiology , Fluconazole/metabolism , Humans , Methotrexate/metabolism , ATP Binding Cassette Transporter, Subfamily B, Member 1/genetics , Transformation, Genetic
SELECTION OF CITATIONS
SEARCH DETAIL